CA2318313A1 - Inhibition of dna modulation caused by mutated p53 - Google Patents

Inhibition of dna modulation caused by mutated p53 Download PDF

Info

Publication number
CA2318313A1
CA2318313A1 CA002318313A CA2318313A CA2318313A1 CA 2318313 A1 CA2318313 A1 CA 2318313A1 CA 002318313 A CA002318313 A CA 002318313A CA 2318313 A CA2318313 A CA 2318313A CA 2318313 A1 CA2318313 A1 CA 2318313A1
Authority
CA
Canada
Prior art keywords
dna
mut
mutated
strand
separating potential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002318313A
Other languages
English (en)
French (fr)
Inventor
Wolfgang Willi Deppert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2318313A1 publication Critical patent/CA2318313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA002318313A 1998-01-26 1999-01-22 Inhibition of dna modulation caused by mutated p53 Abandoned CA2318313A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19802792.3 1998-01-26
DE19802792A DE19802792A1 (de) 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA
PCT/DE1999/000221 WO1999037803A2 (de) 1998-01-26 1999-01-22 HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA

Publications (1)

Publication Number Publication Date
CA2318313A1 true CA2318313A1 (en) 1999-07-29

Family

ID=7855657

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002318313A Abandoned CA2318313A1 (en) 1998-01-26 1999-01-22 Inhibition of dna modulation caused by mutated p53

Country Status (13)

Country Link
EP (1) EP1049810A2 (ja)
JP (1) JP2002507389A (ja)
KR (1) KR100413929B1 (ja)
CN (1) CN1289373A (ja)
AU (1) AU755775B2 (ja)
BR (1) BR9907725A (ja)
CA (1) CA2318313A1 (ja)
DE (2) DE19802792A1 (ja)
NO (1) NO20003762D0 (ja)
PL (1) PL342399A1 (ja)
RU (1) RU2235786C2 (ja)
SK (1) SK11052000A3 (ja)
WO (1) WO1999037803A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348113C (zh) * 2005-05-14 2007-11-14 章建庆 一种食用籼草鱼的制作方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
GB9521544D0 (en) * 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof

Also Published As

Publication number Publication date
BR9907725A (pt) 2001-09-04
WO1999037803A3 (de) 1999-10-14
KR100413929B1 (ko) 2004-01-07
DE19802792A1 (de) 1999-07-29
AU2920099A (en) 1999-08-09
DE19980080D2 (de) 2001-03-29
NO20003762L (no) 2000-07-21
PL342399A1 (en) 2001-06-04
AU755775B2 (en) 2002-12-19
WO1999037803A2 (de) 1999-07-29
RU2235786C2 (ru) 2004-09-10
WO1999037803A9 (de) 1999-11-18
NO20003762D0 (no) 2000-07-21
CN1289373A (zh) 2001-03-28
JP2002507389A (ja) 2002-03-12
EP1049810A2 (de) 2000-11-08
KR20010040407A (ko) 2001-05-15
SK11052000A3 (sk) 2001-05-10

Similar Documents

Publication Publication Date Title
Kinzler et al. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome
Van Wijnen et al. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1
Hatamochi et al. A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding.
Kerrigan et al. Sequence-specific transcriptional antirepression of the Drosophila Krüppel gene by the GAGA factor.
Goldenberg et al. Purified human factor activates heat shock promoter in a HeLa cell-free transcription system.
Stokes et al. DNA-binding and chromatin localization properties of CHD1
Storti et al. Translational control of protein synthesis in response to heat shock in D. melanogaster cells
Foord et al. A DNA binding domain is contained in the C-terminus of wild type p53 protein
US5525490A (en) Reverse two-hybrid method
Osborne et al. Red 25, a protein that binds specifically to the sterol regulatory region in the promoter for 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Rikiyama et al. GCF2: expression and molecular analysis of repression
Ronai et al. Identification of ultraviolet-inducible proteins that bind to a TGACAACA sequence in the polyoma virus regulatory region
Patel et al. Expression of Pax2 in the intermediate mesoderm is regulated by YY1
AU755775B2 (en) Inhibition of DNA modulation caused by mutated p53
Gaillard et al. A sequence-specific single-strand-binding protein for the late-coding strand of the simian virus 40 control region
US20050070495A1 (en) Inhibition of DNA modulation caused by mutated p53
Ruteshouser et al. Purification of BBF, a DNA-binding protein recognizing a positive cis-acting element in the mouse alpha 1 (III) collagen promoter.
MXPA00007319A (en) INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
WO1993008701A1 (en) C-myc dna binding partners, motifs, screening assays, and uses thereof
Rupp et al. TGGCA protein is present in erythroid nuclei and binds within the nuclease‐hypersensitive sites 5′ of the chicken βH‐and βA‐globin genes
RU2201448C2 (ru) Способ модификации связывания p53 или его мутантной формы с геном-мишенью
Coux et al. The protein of Mr 21 000 constituting the prosome‐like particle of duck erythroblasts is homologous to apoferritin
CZ20002714A3 (cs) Inhibice modulace DNA způsobené mutovaným p53
Radtke et al. Phosphorylation affects the DNA affinity of the nuclear protein 24/7 from human tumor cells
Stigare et al. The nuclear 42-kDa phosphoprotein preferentially binds promoter-containing single-stranded DNA

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead